Sexual dysfunction after pelvic surgery

C. Zippe, Kalyana C. Nandipati, A. Agarwal, R. Raina

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

Pelvic surgeries are among the most common causes of organic sexual dysfunction in men and women. The impact of nerve-sparing surgery on potency has been well documented in radical prostatectomy. However, its impact on potency needs to be evaluated in other pelvic surgeries. Sexual dysfunction is highly prevalent even after multiple technical advances in the field of oncological surgeries. The prevalence varies from 8 to 82%, depending on the type of pelvic surgery. In females, sexual dysfunction has not been evaluated adequately using validated questionnaires. However, in subspecialized circles, treatment for female sexual dysfunction is becoming routine. Currently, physicians have several options for the treatment of erectile dysfunction (ED) in men. Since the introduction of oral PDE-5 inhibitors, oral therapy has become the first-line treatment option for ED, irrespective of etiology. Currently available treatment options for the female sexual dysfunction include estrogens, androgens, phosphodiesterase inhibitors, and dopamine receptor antagonists. Initial reports regarding the role of early rehabilitation are encouraging and may become the part of routine practice in the management of ED after pelvic surgery. In this article, we summarize the sexual dysfunction following pelvic surgeries and their management.

Original languageEnglish
Pages (from-to)1-18
Number of pages18
JournalInternational Journal of Impotence Research
Volume18
Issue number1
DOIs
StatePublished - Jan 2006
Externally publishedYes

Fingerprint

Erectile Dysfunction
Therapeutics
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Dopamine Antagonists
Practice Management
Prostatectomy
Androgens
Estrogens
Rehabilitation
Physicians

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Sexual dysfunction after pelvic surgery. / Zippe, C.; Nandipati, Kalyana C.; Agarwal, A.; Raina, R.

In: International Journal of Impotence Research, Vol. 18, No. 1, 01.2006, p. 1-18.

Research output: Contribution to journalReview article

Zippe, C. ; Nandipati, Kalyana C. ; Agarwal, A. ; Raina, R. / Sexual dysfunction after pelvic surgery. In: International Journal of Impotence Research. 2006 ; Vol. 18, No. 1. pp. 1-18.
@article{52c9e560a55247bbaeed00be245104ac,
title = "Sexual dysfunction after pelvic surgery",
abstract = "Pelvic surgeries are among the most common causes of organic sexual dysfunction in men and women. The impact of nerve-sparing surgery on potency has been well documented in radical prostatectomy. However, its impact on potency needs to be evaluated in other pelvic surgeries. Sexual dysfunction is highly prevalent even after multiple technical advances in the field of oncological surgeries. The prevalence varies from 8 to 82{\%}, depending on the type of pelvic surgery. In females, sexual dysfunction has not been evaluated adequately using validated questionnaires. However, in subspecialized circles, treatment for female sexual dysfunction is becoming routine. Currently, physicians have several options for the treatment of erectile dysfunction (ED) in men. Since the introduction of oral PDE-5 inhibitors, oral therapy has become the first-line treatment option for ED, irrespective of etiology. Currently available treatment options for the female sexual dysfunction include estrogens, androgens, phosphodiesterase inhibitors, and dopamine receptor antagonists. Initial reports regarding the role of early rehabilitation are encouraging and may become the part of routine practice in the management of ED after pelvic surgery. In this article, we summarize the sexual dysfunction following pelvic surgeries and their management.",
author = "C. Zippe and Nandipati, {Kalyana C.} and A. Agarwal and R. Raina",
year = "2006",
month = "1",
doi = "10.1038/sj.ijir.3901353",
language = "English",
volume = "18",
pages = "1--18",
journal = "International Journal of Impotence Research",
issn = "0955-9930",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Sexual dysfunction after pelvic surgery

AU - Zippe, C.

AU - Nandipati, Kalyana C.

AU - Agarwal, A.

AU - Raina, R.

PY - 2006/1

Y1 - 2006/1

N2 - Pelvic surgeries are among the most common causes of organic sexual dysfunction in men and women. The impact of nerve-sparing surgery on potency has been well documented in radical prostatectomy. However, its impact on potency needs to be evaluated in other pelvic surgeries. Sexual dysfunction is highly prevalent even after multiple technical advances in the field of oncological surgeries. The prevalence varies from 8 to 82%, depending on the type of pelvic surgery. In females, sexual dysfunction has not been evaluated adequately using validated questionnaires. However, in subspecialized circles, treatment for female sexual dysfunction is becoming routine. Currently, physicians have several options for the treatment of erectile dysfunction (ED) in men. Since the introduction of oral PDE-5 inhibitors, oral therapy has become the first-line treatment option for ED, irrespective of etiology. Currently available treatment options for the female sexual dysfunction include estrogens, androgens, phosphodiesterase inhibitors, and dopamine receptor antagonists. Initial reports regarding the role of early rehabilitation are encouraging and may become the part of routine practice in the management of ED after pelvic surgery. In this article, we summarize the sexual dysfunction following pelvic surgeries and their management.

AB - Pelvic surgeries are among the most common causes of organic sexual dysfunction in men and women. The impact of nerve-sparing surgery on potency has been well documented in radical prostatectomy. However, its impact on potency needs to be evaluated in other pelvic surgeries. Sexual dysfunction is highly prevalent even after multiple technical advances in the field of oncological surgeries. The prevalence varies from 8 to 82%, depending on the type of pelvic surgery. In females, sexual dysfunction has not been evaluated adequately using validated questionnaires. However, in subspecialized circles, treatment for female sexual dysfunction is becoming routine. Currently, physicians have several options for the treatment of erectile dysfunction (ED) in men. Since the introduction of oral PDE-5 inhibitors, oral therapy has become the first-line treatment option for ED, irrespective of etiology. Currently available treatment options for the female sexual dysfunction include estrogens, androgens, phosphodiesterase inhibitors, and dopamine receptor antagonists. Initial reports regarding the role of early rehabilitation are encouraging and may become the part of routine practice in the management of ED after pelvic surgery. In this article, we summarize the sexual dysfunction following pelvic surgeries and their management.

UR - http://www.scopus.com/inward/record.url?scp=30044448076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30044448076&partnerID=8YFLogxK

U2 - 10.1038/sj.ijir.3901353

DO - 10.1038/sj.ijir.3901353

M3 - Review article

C2 - 15988545

AN - SCOPUS:30044448076

VL - 18

SP - 1

EP - 18

JO - International Journal of Impotence Research

JF - International Journal of Impotence Research

SN - 0955-9930

IS - 1

ER -